44
Participants
Start Date
August 31, 2009
Primary Completion Date
August 31, 2010
Study Completion Date
December 31, 2010
CKD-810, Taxotere inj.
Patients will receive docetaxel 75mg/㎡ on Day 1 of each cycle(1 cycle = 3 weeks) as a 1-hour IV infusion. At the 1st cycle, CKD-810 75mg/㎡ administered. If the hematologic or non-hematologic toxicity was not appeared when the 1st cycle intervention was finished, keep going the 2nd cycle intervention.
CKD-810, Taxotere inj.
Patients will receive docetaxel 75mg/㎡ on Day 1 of each cycle(1 cycle = 3 weeks) as a 1-hour IV infusion. At the 1st cycle, Taxotere inj. 75mg/㎡ administered. If the hematologic or non-hematologic toxicity was not appeared when the 1st cycle intervention was finished, keep going the 2nd cycle intervention.
Gachon University Gil Hospital, Inchon
The Catholic university of KOREA, Seoul ST. Mary's Hospital, Seoul
The Korea University Anam Hospital, Seoul
Ajou University Hospital, Suwon
Dongsan Medical Center, Keimyung University, Taegu
Yeoungnam University Hospital, Taegu
Ulsan University Hospital, Ulsan
Lead Sponsor
Chong Kun Dang Pharmaceutical
INDUSTRY